A study to be published in the Journal of Parkinson’s Disease and made available in prepress form shows that a wearable device (Personal KinetiGraph, Global Kinetics Corporation Ltd; Portsmouth, NH) provides significant information from patients with Parkinson’s disease (PD) beyond what is typically captured in clinical visits. In some cases, the data delivered by the device prompted physicians to change their medical management of patients.
The technology is worn by patients at home for several days, and measures motor symptoms of PD. Information gathered is transmitted to the patient’s treating physician for review during the next visit. Using survey methodology, the study concluded that the device provided qualitative data on tremor, bradykinesia, and dyskinesia to the physician that was more than what they could receive in a typical visit without the device.
Of the 112 surveys conducted, 41% indicated that the device provided more information and 78% showed that the data prompted changes to the treatment plan for a patient.
“These results demonstrate the real-world clinical benefits that Personal KinetiGraph can provide to patients and clinicians in their continuing effort to optimize Parkinson’s therapy and manage symptoms effectively,” said John Schellhorn, CEO of Global Kinetics Corporation Ltd. “The results of this study support the use of Personal KinetiGraph as an important tool for individualizing therapy to best meet each patient’s unique needs.”
Shailee S. Shah, MD, and Andrew McKeon, MD
Danielle S. Shpiner, MD; Crystal Dixon, MD; Melissa R. Ortega, MD; and Henry Moore, MD
Michelle L. Dougherty, MD, FAES, FAAN